분자유전학실험실 (단국대학교 분자생물학과)



 이성욱 ( 2017-10-03 20:48:16 , Hit : 497
 Giants of Circadian Biology Win Nobel Prize

The Scientist »
News & Opinion »
Daily News


http://www.the-scientist.com/?articles.view/articleNo/50544/title/Giants-of-Circadian-Biology-Win-Nobel-Prize/&utm_campaign=NEWSLETTER_TS_The-Scientist-Daily_2016&utm_source=hs_email&utm_medium=email&utm_content=56907538&_hsenc=p2ANqtz-8d7xKZDRa5b_ArL82h-ik2tXo0_GIvq7yMm_UPs-7wghnbmdqnrWpnF-9iQyDDgEZuwkmfucvczjryqpDCxFVPOwCXkg&_hsmi=56907538



The award in Physiology or Medicine goes to chronobiologists Jeffrey Hall, Michael Rosbash, and Michael Young.

By Catherine Offord | October 2, 2017



Jeffrey Hall, Michael Rosbash, Michael Young

NOBEL MEDIA. III. N. ELMEHED
The 2017 Nobel Prize in Physiology or Medicine has been jointly awarded to Jeffrey Hall, Michael Rosbash, and Michael Young for their work on circadian rhythms. The trio is recognized for research on the period gene in Drosophila—a central regulator of the circadian clock whose discovery led to the identification of such genes in humans and other animals—plus the protein machinery governing the timing of biological rhythms.

In the course of their research, collaborators Rosbash and Hall at Brandeis University and Young independently at Rockefeller University, “solved the mystery of how an inner clock in most of our cells in our bodies can anticipate daily fluctuations between night and day to optimize our behavior and physiology,” Thomas Perlmann, secretary general for the Nobel Assembly and Nobel Committee, says in a statement.

Russell Foster, head of the Sleep and Circadian Neuroscience Institute at the University of Oxford, tells The Scientist that he’s “thrilled and delighted” by the news. “These are the people who gave us our first working model of how the molecular clock might tick. The three of them . . . have formed the platform of our understanding of the molecular basis of circadian rhythms, not only in flies, but it’s informed the work in mice and humans.”

Retired since 2008, Jeffrey Hall was at Brandeis University from 1974, where he took an early interest in the biology of circadian rhythms in Drosophila. His initial work with period showed that the gene played an important role in regulating the rhythm of courtship song cycles produced by male fruit flies (PNAS, 77:6729-33, 1980).

Hall later began collaborating with Brandeis colleague Michael Rosbash—a neuroscientist he got to know primarily through sport, colleagues say. The pair went on to isolate the period gene—which had been described in the 1970s by Seymour Benzer and Ronald Konopka—and showed that it produced a protein, PER, that cycles on a daily rhythm (Cell, 39:369-76, 1984). Rockefeller’s Michael Young and colleagues simultaneously isolated period, publishing the findings in Nature the same year (312:752-54).


These are the people who gave us our first working model of how the molecular clock might tick.—Russell Foster,
University of Oxford

The research laid the groundwork for other researchers to map similarly essential circadian genes in mice and other animals. “What’s extraordinary is that the basic building blocks of the clock discovered in flies are very similar in mice and humans,” says Foster. “It’s broadly the same genes and broadly the same proteins.”

The trio went on to pin down the details of the protein machinery governing circadian rhythms. Working with postdoctoral researcher Paul Hardin, Hall and Rosbash showed that mRNA transcripts from the period gene also cycle, allowing the PER protein to regulate its own production via a feedback loop (Nature, 343:536-40, 1990). “It was a great experience working as a postdoc,” Hardin tells The Scientist, adding that he is pleased and not overly surprised about today’s news. “Their work for a number of years has merited an award of this magnitude. I was so happy to hear the news this morning.”

Young, meanwhile, discovered a number of other genes influencing period protein dynamics. In 1994, his group identified timeless, a clock gene that produces a protein, TIM, that binds to PER, and is required for the latter’s entry into the nucleus to regulate period gene expression (Science, 263:1603-6). A few years later, the team described another gene, double-time, which regulates the accumulation of the period protein (Cell, 94:83-95, 1998). “He’s just a terrific scientist,” says collaborator Brian Crane, a biochemist at Cornell University. “His impact is huge. I figured that sooner or later this would happen, but it’s nice to see it materialize.”

It’s not the first time the laureate trio has been recognized for contributions to biology and the research into human circadian rhythms that has followed. In 2009, the Gruber Foundation awarded the Neuroscience Prize to Hall, Rosbash, and Young for the establishment of “a direct link between genes and behavior” that could later be extended beyond fruit flies into humans and, indeed, “all living organisms.”

In 2012, the three were recognized again with the Canada Gairdner International Award for pioneering science’s understanding of the circadian rhythm. “The medical relevance of these findings has become apparent as it was found that changes in these clock genes are associated with a series of sleep disorders in humans,” Young said in an interview at the time. “There are strong indications that some forms of depression are linked to the control of circadian rhythms.”

All three have made an impression inside and outside the lab. “Being in the room with them, you realize you have to keep concentration to keep up with the discussion,” notes Michael Hastings, a molecular neurobiologist working on circadian rhythms at the University of Cambridge, who sees both Rosbash and Young frequently at research gatherings. “[They have] an enormous intellectual appetite and curiosity.”

On announcing the prize, Rosbash’s first response to the news of the award this morning was “you are kidding me,” Perlmann told the audience. “That’s a classic Michael response,” Hardin says. “He’s quite the jokester.”







1227   암 면역요법, 일부 환자에게만 효과 있는 이유  이성욱 2018/01/12 587
1226   [바이오토픽] CRISPR 기반 유전자치료를 방해하는 면역계  이성욱 2018/01/10 589
1225   [미국] 2017년, 유전자가위 기술을 통한 네 가지 사건들  이성욱 2018/01/10 531
1224   Using Oncolytic Viruses to Boost Response to Immune Checkpoint Inhibitors  이성욱 2018/01/05 836
1223   Alcohol Boosts Cancer Risk by Damaging Stem Cell DNA  이성욱 2018/01/05 508
1222   [바이오토픽] Science, 2017년 과학연구 총결산  이성욱 2017/12/27 1006
1221   FDA Approves First Gene Therapy for Inherited Disease  이성욱 2017/12/22 510
1220   Spark Therapeutics shares rise on FDA approval of new gene therapy for blindness  이성욱 2017/12/20 368
1219   작년 바이오산업 규모 8조8775억원, 투자 13.9% 늘어  이성욱 2017/12/13 489
1218   CRISPR/Cas9 Edits Epigenome with Therapeutic Efficiency  이성욱 2017/12/09 484
1217   [바이오토픽] 체크포인트 저해제의 부작용: 자가면역질환 초래  이성욱 2017/11/16 685
1216   DNA Repair Mechanism Aids Cancer by Mending Chemo Damage  이성욱 2017/11/10 566
1215   FDA Approves Gilead CAR-T Therapy Yescarta, Plans Regenerative Medicine Policy 'Soon'  이성욱 2017/10/20 607
1214   Advisors to FDA Recommend Approval of Gene Therapy for Blindness  이성욱 2017/10/14 663
1213   CRISPR System Targets RNA in Mammalian Cells  이성욱 2017/10/06 639
1212   Nonviral CRISPR Delivery a Success  이성욱 2017/10/03 554
  Giants of Circadian Biology Win Nobel Prize  이성욱 2017/10/03 497
1210   To Speed CRISPR/Cas9’s Search and Snip, Try Extra Cas9 and gRNA  이성욱 2017/09/30 1988
1209   Technique Adapted from CRISPR-Cas9 Corrects Mutation in Human Embryos  이성욱 2017/09/29 502
1208   Mutations Making CRISPR Hyper-Accurate Discovered  이성욱 2017/09/22 850

[1][2] 3 [4][5][6][7][8][9][10]..[64] [다음 10개]
 

Copyright 1999-2021 Zeroboard / skin by ROBIN